Johnson & Johnson (JNJ) vs Coca-Cola (KO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Johnson & Johnson (JNJ) has outperformed Coca-Cola (KO) over the past year, gaining 35.2% versus a gain of 32.7%. Over five years, KO leads with a +61.1% price change compared with +59.0% for JNJ. Johnson & Johnson is the larger company by market cap ($618.09 billion vs $377.63 billion), about 1.6 times the size.
On valuation, Johnson & Johnson trades at a lower forward P/E (21.2x vs 24.9x for Coca-Cola). Coca-Cola offers the higher dividend yield (2.37% vs 2.04%). Johnson & Johnson converts more of its revenue into profit, with a net margin of 28.5% versus 27.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | JNJ | KO |
|---|---|---|
| Share price | $256.48 | $87.77 |
| Market cap | $618.09B | $377.63B |
| 1-day change | -0.76% | +2.27% |
| YTD return | +23.93% | +25.55% |
| 1-year return | +35.21% | +32.74% |
| 5-year return | +59.01% | +61.10% |
| P/E ratio (TTM) | 29.96 | 26.36 |
| Forward P/E | 21.19 | 24.90 |
| EPS (TTM) | $8.56 | $3.33 |
| Dividend yield | 2.04% | 2.37% |
| Annual dividend | $5.24 | $2.08 |
| Revenue (latest FY) | $94.19B | $47.94B |
| Revenue growth (YoY) | +6.05% | +1.87% |
| Net income (latest FY) | $26.80B | $13.11B |
| Gross margin | 67.88% | 61.63% |
| Operating margin | — | 28.71% |
| Net margin | 28.46% | 27.34% |
| 52-week high | $281.07 | $92.49 |
| 52-week low | $184.66 | $66.00 |
| Distance from 52-week high | -8.75% | -5.10% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +9.03% | +7.59% |
| Average volume | 7.01M | 15.85M |
| Shares outstanding | 2.41B | 4.30B |
| Employees | 138,200 | 65,900 |
| Sector | Health Care | Consumer Staples |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Johnson & Johnson in Health Care and Coca-Cola in Consumer Staples.
About Johnson & Johnson
JNJ stock →Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
Health Care · Biotechnology: Pharmaceutical Preparations · 138,200 employees
About Coca-Cola
KO stock →The Coca-Cola Company, a beverage company, manufactures and sells various nonalcoholic beverages in the United States and internationally. The company provides Trademark Coca-Cola, sparkling soft drinks and flavors; water, sports, coffee, and tea; juice, value-added dairy, and plant-based beverages; and emerging beverages.
Consumer Staples · Beverages (Production/Distribution) · 65,900 employees
JNJ vs KO FAQ
Which is bigger, Johnson & Johnson or Coca-Cola?
Johnson & Johnson (JNJ) is larger, with a market capitalization of $618.09B compared with $377.63B for Coca-Cola (KO).
Which stock has performed better over the past year, JNJ or KO?
JNJ returned +35.21% over the past 12 months, compared with +32.74% for KO (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, JNJ or KO?
KO has the lower trailing P/E at 26.4, versus 30.0 for JNJ. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Johnson & Johnson or Coca-Cola?
Coca-Cola has the higher yield at 2.37%, compared with 2.04% for Johnson & Johnson.
Are Johnson & Johnson and Coca-Cola in the same industry?
No. Johnson & Johnson is in the Health Care sector, while Coca-Cola is in Consumer Staples.